ThursdayAug 16, 2018 12:12 pm

QualityStocksNewsBreaks – Auscrete Corp. (ASCK) Offers Unique Path to Affordable Home Ownership

Auscrete (OTC: ASCK) aims to offer turnkey houses for roughly $100 per square foot, which is significantly less than the 2017 median list price of $148 per square foot. A recent article discussing the company reads: “This impressive feat can be accomplished because Auscrete produces hybrid cementitious building products in the form of wall and roof segments that are infused with millions of minuscule air “aggregates” that are evenly distributed throughout the cast sections. This creates a superior, lightweight product, without compromising strength or structural integrity. Each hybrid panel also incorporates a distinctive XPS insulation composition that ensures greater comfort…

Continue Reading

ThursdayAug 16, 2018 12:08 pm

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Advances Development of HIV Single Agent Therapy

Biotechnology company CytoDyn (OTCQB: CYDY) recently reported significant developmental progress during phase 3 trials for its PRO 140 monotherapy for human immunodeficiency virus (HIV) after observing enhanced response rates at higher doses of the treatment (http://ibn.fm/yuYub). An article discussing the company’s progress reads: “The dosage increase will apply to all newly enrolled patients but also to current trial participants who failed to maintain suppressed HIV viral load on a lower dose. Approximately 70 percent of trial participants who started PRO 140 at 525 mg and have been undergoing treatment between one and nine months are achieving HIV viral load suppression,…

Continue Reading

ThursdayAug 16, 2018 11:37 am

Pressure BioSciences Inc. (PBIO) Reports Significant Financial and Operational Achievements during Highly Successful Q2

Pressure BioSciences Inc. announced strong financial results for the second quarter of 2018, demonstrating the company’s growth and stability Products and services revenue increased for the tenth consecutive quarter (YoY) while registering growth of 29 percent compared to Q2 2017 Company sets all-time first half fiscal year total revenue record A partnership with Ohio State University will enable the company to seek expansion in new industries like food, beverages, pharmaceuticals and cosmetics Pressure BioSciences Inc. (OTCQB: PBIO) recently announced its financial results for the second quarter of 2018, highlighting one of the most successful periods in the history of the…

Continue Reading

ThursdayAug 16, 2018 11:27 am

Independent Researchers at SeeThruEquity Take Note of Advances at Payment Solutions Company Net Element, Inc. (NASDAQ: NETE)

Rise in transaction volume, product enhancements and asset acquisition show Net Element’s ongoing growth strategy SeeThruEquity labels Net Element an ‘intriguing’ high-risk, high-reward growth company with stable share price target Since 2014, Net Element’s revenues from payment processing services have nearly tripled A series of optimistic developments for payment tech processor Net Element, Inc. (NASDAQ: NETE) has led independent equity research firm SeeThruEquity to issue an update of its coverage on the company (http://ibn.fm/7NBjg). The research firm is taking note of Net Element’s forecast for an increase in gross profits based on its acquisition of services assets from partner Universal Payment…

Continue Reading

ThursdayAug 16, 2018 9:57 am

QualityStocksNewsBreaks – Zenergy Brands, Inc. (ZNGY) Reports Q2 Financial Results

Next-generation energy and technology company Zenergy Brands (OTC: ZNGY) this morning announced that it has filed its Form 10-Q with the SEC, reporting financials from the second quarter of 2018. The company reported total revenue of $464,404 during the second quarter of 2018, demonstrating an increase of 54% when compared to the total revenue of $301,809 from the previous quarter. Zenergy attributes the revenue growth primarily to the company’s retail electricity services, and energy conservation and efficiency contracts. The company also reported an increase in growth profit of 17% from the previous quarter, totaling $109,315 for Q2. Zenergy’s Zero Cost…

Continue Reading

ThursdayAug 16, 2018 9:26 am

QualityStocksNewsBreaks – FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) Unveils New FANbassador Program

  Fan-focused entertainment company FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) this morning unveiled its new FANbassador Program. The company is giving users and fans of its FANDOM SPORTS app the chance to become contributing writers on the app for a week. Interested users can submit their best sports fights to nick@fandomsports.net. The top three fights with the best headlines and pictures will win a chance to become a paid FANbassador writer for a week. In the future, the company intends to give official FANbassadors a chance to pick a fight and talk trash on the FANDOM…

Continue Reading

WednesdayAug 15, 2018 2:29 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Continues to Demonstrate Versatility

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is the developer of a disruptive drug delivery platform, DehydraTECH™, that the company out-licenses to entities aiming to deliver healthier ingestion methods of cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. An article discussing the company’s technology reads: “Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) patented DehydraTECH™ drug delivery platform has already received some eight patents granted and nearly 50 pending worldwide, and the company has applied for one more to the USPTO. This is because, in lab studies, the proprietary technology has shown evidence of transporting active pharmaceutical ingredients (APIs) across…

Continue Reading

WednesdayAug 15, 2018 2:22 pm

QualityStocksNewsBreaks –The Flowr Corp. Secures Sales License from Health Canada

The Flowr Corp., a cultivator of premium cannabis in Canada, recently announced that it has received its sales license from Health Canada enabling the company to sell to the Canadian medical and adult-use recreational markets. Initially, Flowr will offer two brands: FlowrRx and Flowr. FlowrRx is a premium quality medicinal cannabis that empowers patients to live improved, fuller lives. The company’s premium recreational adult-use brand, Flowr, will serve the recreational market when it opens in October. “We’re pleased to have successfully completed the rigorous Health Canada sales licensing process and are excited to begin offering consumers and patients the high-quality…

Continue Reading

WednesdayAug 15, 2018 12:41 pm

CytoDyn Inc. (CYDY) Sees Promising HIV Treatment Trial Results, Gets Go-Ahead to Raise Dosage

Response rate to PRO 140 rose from 40 percent at 350mg dose to 70 percent at 525mg Institutional Review Board (IRB) allows trials of viral-entry inhibitor to continue at 700mg dose PRO 140 is an FDA fast-track candidate Following clinical trial results showing that its new anti-HIV treatment is more effective at higher dosages, biotechnology company CytoDyn Inc. (OTCQB: CYDY) is set to give trial participants an increased weekly dose of PRO 140 (http://ibn.fm/oyLRe). The latest round of trial results showed that the response rate among trial participants treated with the viral-entry inhibitor rose from 40 percent at a 350mg weekly…

Continue Reading

WednesdayAug 15, 2018 12:17 pm

MIDS Cardiac by Zenosense, Inc. (ZENO): A Heart Attack Diagnostic Revolution?

The handheld testing device technology under development by Zenosense aims to deliver rapid results and state-of-the-art, laboratory-accurate results for the quick diagnosis of heart attacks Medical professionals believe that diagnosis within 30 minutes of a heart attack is the golden standard for ensuring adequate treatment Cardiac diagnostic testing market estimated between $2 billion and $6 billion in the U.S. alone MIDS Cardiac™, a handheld diagnostic device for cardiac emergency triage being developed by Zenosense, Inc. (OTCQB: ZENO), could prove to be revolutionary in the diagnostic process. Incorporating the patented MIDS technology, which is predicated on the nano-magnetic detection of assay…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered